CCM
MOR

Chilton Capital Management’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Chilton Capital Management’s Portfolio MOR Stock Details MOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100
Closed -$1K – 637
2021
Q4 		$1K Buy
+100
New +$1.06K ﹤0.01% 640

Other funds holding MOR

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
HJIM
Henry James International Management New York $334M AUM 49.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Chilton Capital Management's MOR Position: Q1 2022 in Review

Chilton Capital Management sold out of MorphoSys AG American Depositary Shares (MOR) in Q1 2022, closing a stake of 100 shares — an estimated $1K sold.

Chilton Capital Management first reported a position in MOR in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 23 funds tracked by Wall St. Rank hold MOR as of Q1 2022.

  • Chilton Capital Management reported no remaining MorphoSys AG American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Chilton Capital Management sold 100 MorphoSys AG American Depositary Shares shares in Q1 2022, an estimated $1K.
  • Chilton Capital Management first reported a position in MorphoSys AG American Depositary Shares in Q4 2021 and held it in 1 quarter.
  • Chilton Capital Management's MorphoSys AG American Depositary Shares position peaked at $1K in Q4 2021.
  • 23 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q1 2022.

Based on Chilton Capital Management's 13F filing for Q1 2022, filed 16 May 2022.